We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVI Global Trust Regulatory News (AGT)

Share Price Information for AVI Global Trust (AGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 235.50
Bid: 235.50
Ask: 236.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.425%)
Open: 235.00
High: 235.50
Low: 235.00
Prev. Close: 235.50
AGT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Newsletter

17 Mar 2020 16:33

RNS Number : 5107G
AVI Global Trust PLC
17 March 2020
 

 

AVI GLOBAL TRUST PLC

 

Monthly Update

 

AVI Global Trust plc (the "Company") presents its Update, reporting performance figures for the month ended 29 February 2020.

 

This Monthly Newsletter is available on the Company's website at:

https://www.aviglobal.co.uk/content/uploads/2020/03/AVI-Global-Trust-2020-FEB.pdf 

 

Performance Total Return

 

This investment management report relates to performance figures to 29 February 2020.

 

Month

Financial Yr *

to date

Calendar Yr

to date

AGT NAV1

-8.9%

-7.0%

-10.0%

MSCI ACWI Ex US3

-5.0%

-5.8%

-7.1%

MSCI ACWI Ex US Value1

-5.6%

-8.8%

-9.4%

MSCI ACWI1

-5.1%

-4.4%

-5.7%

Morningstar Global Growth1

-4.8%

-3.0%

-5.7%

 

* AVI Global Trust financial year commences on the 1st October. All figures published before the fiscal results announcement are AVI estimates and subject to change.

1 Source: Morningstar. All NAV figures are cum-fair values.

2 Source: Morningstar. Share price total return is on a mid-to-mid basis, with net income re-invested.

3 From 1st October 2013 the lead benchmark was changed to the MSCI ACWI ex US (£) Index. The investment management fee was changed to 0.7% of net assets and the performance related fee eliminated.

 

 

Manager's Comment

 

AVI Global Trust (AGT)'s NAV fell by -8.9% in February as global markets sold off in response to the spread of Coronavirus. The decline was driven both by NAV declines and a widening of the portfolio discount from 32% to 36%, with sterling strength softening some of the losses. Contributors over the month include Vietnam Phoenix 'C', Swire Pacific 'B' and JPEL Private Equity. Major detractors include the Japan Special Situations basket, Oakley Capital Investments, Sony Corp and Pershing Square Holdings.

 

The Japan Special Situations basket was AGT's largest negative contributor, reducing returns by -220 basis points (bps). Japan has been near the epicentre of the viral outbreak, with the third-highest number of cases in Asia outside China or South Korea. The TOPIX has declined -21% from the start of February to the time of writing, and the Japan basket has fallen by -26%, in line with the TOPIX Small. As a result of the sell-off, there are now six stocks in the basket where net financial value (net cash + investment securities) is 100% of market value or greater, and three stocks have greater than 100% of their market value in cash. With such valuations, the market is implying a zero or negative value to the earnings of the underlying businesses. Even in times of distress, it is difficult to see the rationality behind assigning a zero/negative valuation to businesses which we believe, over the medium- to long-term, are capable of generating positive, growing earnings and cash-flows.

 

Oakley Capital Investments (OCI) was the second-largest detractor, contributing -100bps. The discount widened from 21% to 30%, resulting in share price returns of -12%. OCI released a trading update in late January, which revealed total NAV growth for 2019 of +25%, making OCI the strongest-performing London-listed private equity vehicle in 2019 - a significant achievement.

 

2019's share price returns were even better at +56%, boosted by a tightening discount. 2019 was a strong year for OCI, with two notable exits at significant uplifts to carrying value (Inspired, WebPros), and five new investments into attractive companies (Ekon, Seagull/Videotel, Alessi, Seven Miles, and Contabo). The new investments were acquired at an average EV/EBITDA of 10x, and the overall portfolio is carried at 12x with earnings growing at +30% annually. On the corporate governance front, significant progress was also made - the company re-listed onto the Specialist Fund Segment (away from the AIM segment, where shareholder protections are less robust), and committed to following many of the regulations governing premium-listed funds. Perhaps most importantly, OCI committed in its SFS-listing prospectus to not issue shares at a discount to NAV unless offered pro rata to all investors - further buttressing similar statements made by the Board. It also bought back 3% of shares, initiated a winding-down of the debt facilities provided to Oakley's LP funds, and announced an elimination of the fees charged on direct debt investments.

 

Since we last discussed OCI (December 2019 factsheet), it has made several announcements: (1) the sale of atHome (1% of NAV), a Luxembourg-based property, mortgage, and autos portal, at a +66% uplift to carrying value; and (2) Fund III's planned acquisition and combination of Rastreator and Acierto, two of Spain's largest price comparison websites, fell through on competition grounds; and (3) the acquisition of Globe-Trotter, a UK-based manufacturer of luxury travel baggage. Similar to Alessi, Globe-Trotter is a unique heritage brand which, with the help of fresh capital and Oakley's operational experience, should be able to build out its sales and distribution capacity and expand geographically.

 

With a robust pipeline of future deals, an attractive, fast-growing portfolio acquired at reasonable multiples, and a significant 30% discount to NAV, we continue to view OCI as a highly attractive investment proposition.

 

While our investment in Pershing Square Holdings (PSH) detracted 41bps from returns over February, a month-end NAV almost 4% higher than expected surprised the market. The company later confirmed they have put on hedges against the impact of the Coronavirus, which they expect to have a "substantial negative impact on the US and global economies". The subsequent NAV - as at 9th March - showed a very material positive impact from these hedges that we estimate to be in the region of +26%. As at the date of this last published NAV, PSH's NAV was up +2.8% over 2020 vs a 14.7% decline from the S&P 500 despite its portfolio companies underperforming the index over that period. One of the criticisms levelled at PSH despite its very strong NAV performance in 2019 was that investors are paying "hedge fund" fees (1.5% of NAV plus 16% of absolute gains) for a long-only portfolio. This line of attack now looks far less valid and, if management can continue to successfully navigate this market sell-off, we would expect to see PSH's discount - which we already felt unjustifiable, notwithstanding certain corporate governance concerns - narrow in response to changed perceptions.

 

AGT initiated a new position in Softbank Group, which now accounts for 4.3% of NAV, making it a top ten position in the portfolio. Softbank is a Japanese holding company whose main assets include Alibaba (59% of NAV), the Chinese e-commerce giant; Softbank Corp (19%), a domestic Japanese telecoms business; Sprint Corp (15%) a US telecoms business; the Softbank Vision Fund (11%), a portfolio of early-stage, disruptive VC companies; and ARM (12%), the UK-based chip manufacturer. Softbank has been very much in the spotlight of late, following its involvement in the WeWork debacle - an issue which, among others, has weighed on the share price, leading to an estimated discount of 60% to NAV. The negative commentary around the Vison Fund, while understandable, is far out of proportion to its weight in Softbank's NAV. We believe there are several levers to pull to enhance value and reduce the discount, including: reducing stakes in Alibaba or Softbank Corp in order to fund NAV-accretive buybacks; and enhancing transparency over the portfolio, particularly with regards to the Vision Fund, which many investors perceive as a 'black box'.

 

We have been invested in Softbank in the past and follow the company closely. While we have long thought the discount attractive and very "solvable", it has been hard to identify a catalyst for a re-rating. In that respect, the investment by Elliot Advisors, a deep-pocketed activist, is a potential game-changer. Following the month end, Softbank announced a JPY500bn share buyback programme, equivalent to 6% of market value.

 

At the time of writing (12.03), AGT's double discount (which combines the portfolio discount with AGT's share price discount to NAV) was 47% - the widest level since 2006, exceeding even those reached during the 2007/8 financial crisis (39%) and the Eurozone crisis (41%).

 

 

 

Contributors / Detractors (in GBP)

 

Largest Contributors

1 month contribution

bps

Percent of NAV

VIETNAM PHOENIX FUND

12

0.7

SWIRE PACIFIC

6

4.0

 

Largest Detractors

1 month contribution

bps

Percent of NAV

JAPAN SPECIAL SITUATIONS**

-220

17.1

OAKLEY CAPITAL INVESTMENTS

-100

7.9

** A basket of 16 stocks: Daiwa Industries, Fujitec Co, Kanaden Corp, Kato Sangyo Co, Konishi Co, Mitsuboshi Belting, Nakano Corp, Nishimatsuya Chain Co, Pasona Group, Sekisui Jushi Corp, SK Kaken, Tachi-S Co, Teikoku Sen-I Co, Toagosei Co, Digital Garage, DTS Corp.

 

 

Link Company Matters Limited

Corporate Secretary

 

17 March 2020

 

LEI: 213800QUODCLWWRVI968

 

The content of the Company's web-pages and the content of any website or pages which may be accessed through hyperlinks on the Company's web-pages, other than the content of the Newsletter referred to above, is neither incorporated into nor forms part of the above announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGPUPWWUPUGQM
Date   Source Headline
23rd Apr 20241:00 pmRNSNet Asset Value(s)
22nd Apr 202412:54 pmRNSNet Asset Value(s)
19th Apr 20245:35 pmRNSTransaction in Own Shares
19th Apr 20243:39 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
18th Apr 20245:40 pmRNSTransaction in Own Shares
18th Apr 202412:18 pmRNSNet Asset Value(s)
17th Apr 202412:24 pmRNSNet Asset Value(s)
16th Apr 202412:31 pmRNSNet Asset Value(s)
15th Apr 202412:44 pmRNSNet Asset Value(s)
12th Apr 20245:30 pmRNSTransaction in Own Shares
12th Apr 20242:09 pmRNSNet Asset Value(s)
11th Apr 20245:49 pmRNSTransaction in Own Shares
11th Apr 202412:59 pmRNSNet Asset Value(s)
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20241:01 pmRNSNet Asset Value(s)
9th Apr 20245:40 pmRNSTransaction in Own Shares
9th Apr 20243:48 pmRNSMonthly Factsheet
9th Apr 202412:20 pmRNSNet Asset Value(s)
9th Apr 202411:56 amRNSDirector/PDMR Shareholding
8th Apr 20244:58 pmRNSDirector/PDMR Shareholding
8th Apr 202412:58 pmRNSNet Asset Value(s)
8th Apr 202412:53 pmRNSAppointment of Corporate Broker
8th Apr 202412:39 pmRNSListing Rule 15.6.8
5th Apr 20241:57 pmRNSNet Asset Value(s)
4th Apr 20245:32 pmRNSTransaction in Own Shares
4th Apr 20241:13 pmRNSNet Asset Value(s)
3rd Apr 20245:32 pmRNSTransaction in Own Shares
3rd Apr 20242:28 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSKepler Trust Intelligence: New Research
2nd Apr 20245:30 pmRNSTransaction in Own Shares
2nd Apr 20244:32 pmRNSNet Asset Value(s)
2nd Apr 202412:31 pmRNSTotal Voting Rights
28th Mar 20245:32 pmRNSTransaction in Own Shares
28th Mar 20242:08 pmRNSNet Asset Value(s)
27th Mar 20245:48 pmRNSTransaction in Own Shares
27th Mar 20243:27 pmRNSNet Asset Value(s)
26th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20242:12 pmRNSNet Asset Value(s)
25th Mar 20245:29 pmRNSTransaction in Own Shares
25th Mar 20242:00 pmRNSNet Asset Value(s)
22nd Mar 20245:33 pmRNSTransaction in Own Shares
22nd Mar 20242:08 pmRNSNet Asset Value(s)
21st Mar 20245:29 pmRNSTransaction in Own Shares
21st Mar 202412:51 pmRNSNet Asset Value(s)
20th Mar 20245:37 pmRNSTransaction in Own Shares
20th Mar 20242:02 pmRNSNet Asset Value(s)
19th Mar 20245:15 pmRNSTransaction in Own Shares
19th Mar 20241:40 pmRNSNet Asset Value(s)
18th Mar 20241:45 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.